UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-03 | Future report Set alerts | |
| Q2 2022 | 2022-08-08 | -0.12 | -0.12 |
| Q1 2022 | 2022-05-09 | -0.09 | -0.09 |
| Q4 2021 | 2022-03-28 | -0.09 | -0.09 |
| Q3 2021 | 2021-11-04 | -0.13 | -0.13 |
| Q2 2021 | 2021-08-02 | -0.10 | -0.10 |
| Q1 2021 | 2021-05-11 | -0.09 | -0.09 |
| Q4 2020 | 2021-03-18 | -0.12 | -0.12 |
| Q2 2020 | 2020-08-10 | -0.14 | -0.14 |
| Q1 2020 | 2020-05-07 | -0.35 | -0.35 |
| 2016-03-07 | Reiterated Rating | HC Wainwright | Buy | $5.00 |
| 2016-01-13 | Upgrade | Cantor Fitzgerald | Hold to Buy | $4.00 |
| 2015-11-11 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2015-11-11 | Reiterated Rating | Oppenheimer Holdings Inc. | Market Perform | |
| 2015-09-29 | Lower Price Target | Jefferies Group | $18.00 to $2.00 | |
| 2015-09-29 | Lower Price Target | HC Wainwright | Buy | $17.00 to $5.00 |
| 2015-09-29 | Downgrade | JMP Securities | Outperform to Market Perform | |
| 2015-09-29 | Downgrade | Raymond James | Strong-Buy to Outperform | $12.00 to $3.00 |
| 2015-09-29 | Downgrade | Raymond James Financial Inc. | Strong-Buy to Outperform | $12.00 to $3.00 |
| 2015-09-28 | Downgrade | Roth Capital | Buy to Neutral | $23.00 to $2.00 |
| 2015-09-28 | Downgrade | Cantor Fitzgerald | Buy to Hold | $22.00 to $4.00 |
| 2015-09-28 | Downgrade | Jefferies Group | Buy to Hold | $18.00 to $2.00 |
| 2015-09-28 | Downgrade | Mizuho | Buy to Neutral | $21.00 to $2.00 |
| 2015-09-17 | Reiterated Rating | HC Wainwright | Buy | $17.00 |
| 2015-09-11 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2015-09-09 | Initiated Coverage | Raymond James | Strong-Buy | |
| 2015-08-28 | Reiterated Rating | Roth Capital | Buy | $23.00 |
| 2015-08-27 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2015-08-26 | Reiterated Rating | Mizuho | Buy | $21.00 |
| 2015-08-11 | Reiterated Rating | Mizuho | Buy | |
| 2015-08-10 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2015-07-02 | Reiterated Rating | Mizuho | Buy | |
| 2015-06-29 | Initiated Coverage | HC Wainwright | Buy | $17.00 |
| 2015-04-27 | Initiated Coverage | Oppenheimer | Market Perform | |
| 2015-04-08 | Initiated Coverage | HC Wainwright | Buy | $16.00 |
| 2015-03-11 | Lower Price Target | Jefferies Group | Buy | $21.00 to $18.00 |
| 2015-01-23 | Lower Price Target | Roth Capital | Buy | $29.00 to $23.00 |
| 2015-01-12 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2015-01-09 | Set Price Target | Roth Capital | Buy | $29.00 |
| 2015-01-09 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2014-12-16 | Initiated Coverage | Wells Fargo & Co. | Outperform | |
| 2014-12-16 | Initiated Coverage | Wells Fargo | Outperform | |
| 2014-08-08 | Boost Price Target | Guggenheim | Buy | $18.00 to $21.00 |
| 2014-07-11 | Reiterated Rating | Deutsche Bank | Buy | $14.00 |
| 2014-07-11 | Reiterated Rating | Deutsche Bank AG | Buy | $14.00 |
| 2014-07-07 | Initiated Coverage | Oppenheimer | Outperform to Market Perform | $8.99 |
| 2014-05-06 | Initiated Coverage | Deutsche Bank | Buy | $14.00 |
| 2014-02-10 | Initiated Coverage | Mizuho | Buy | $21.00 |
| 2013-07-09 | Initiated | Cantor Fitzgerald | Buy | $22 |
| 2016-03-07 | Reiterated Rating | HC Wainwright | Buy | $5.00 |
| 2016-01-13 | Upgrade | Cantor Fitzgerald | Hold to Buy | $4.00 |
| 2015-11-11 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2015-11-11 | Reiterated Rating | Oppenheimer Holdings Inc. | Market Perform | |
| 2015-09-29 | Lower Price Target | Jefferies Group | $18.00 to $2.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In VSTM 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| CHP III LP | 9.01% (2329121) | VSTM / |
| CLARKE JOHN K | 9.01% (2329121) | ALNY / MNTA / VSTM / |
| Longwood Fund, L.P. | 7.43% (1919898) | OVAS / VSTM / |
| Westphal Christoph H Chief Executive Officer | 2.57% (665224) | OVAS / VSTM / |
| ALDRICH RICHARD | 1.58% (408142) | CNCE / OVAS / PTCT / VSTM / |
| Forrester Robert Chief Operating Officer | 0.85% (218734) | IMMU / MYRX / VSTM / |
| BARBERICH TIMOTHY J | 0.50% (130000) | DARA / HTWR / TKAI / VSTM / |
| Pachter Jonathan VP, Head of Research | 0.24% (62249) | VSTM / |
| Phanstiel S. Louise | 0.10% (26500) | MYGN / VSTM / |
| Paterson Dan Head of Corp. Dev, Diagnostics | 0.07% (18286) | VSTM / |
| TERMEER HENRI A | 0.05% (14000) | AGN / AVEO / VSTM / |
| FRIEDMAN PAUL A | 0.01% (3000) | AUXL / CERU / DRTX / INCY / SNTA / VSTM / |
| SHERWIN STEPHEN A | 0.01% (2500) | BIIB / NBIX / RIGL / VICL / VSTM / |
| GREEN JOHN B Chief Financial Officer | 0.01% (2500) | DRNA / VSTM / |
| LAWTON ALISON FRANCIS | 0.01% (2500) | CBST / OVAS / VSTM / |
| Singh Monica General Counsel | 0.01% (2000) | VSTM / |
UM